Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma

被引：0
|
作者：
M. Reni
S. Cereda
E. Bonetto
M. G. Viganò
P. Passoni
A. Zerbi
G. Balzano
R. Nicoletti
C. Staudacher
V. Di Carlo
机构：
[1] San Raffaele Scientific Institute,Department of Oncology
[2] San Raffaele Scientific Institute,Department of Surgery
[3] San Raffaele Scientific Institute,Department of Radiology
来源：
Cancer Chemotherapy and Pharmacology | 2007年 / 59卷
关键词：
Pancreatic cancer; Chemotherapy; PEFG regimen; Dose-intense PEFG;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
    Reni, M.
    Cereda, S.
    Bonetto, E.
    Vigano, M. G.
    Passoni, P.
    Zerbi, A.
    Balzano, G.
    Nicoletti, R.
    Staudacher, C.
    Di Carlo, V.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (03) : 361 - 367
  • [2] Dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma:: A dose-finding study
    Reni, M.
    Cereda, S.
    Bonetto, E.
    Vigano, M. G.
    Passoni, P.
    Zerbi, A.
    Balzano, G.
    Nicoletti, R.
    Staudacher, C.
    Di Carlo, V.
    [J]. CANCER INVESTIGATION, 2007, 25 (07) : 594 - 598
  • [3] Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma
    Reni, M.
    Cereda, S.
    Passoni, P.
    Bonetto, E.
    Vigano, M. G.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI51 - XI51
  • [4] Phase IV trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinoma.
    Reni, M.
    Cereda, S.
    Passoni, P.
    Bonetto, E.
    Viganò, M. G.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 208S - 208S
  • [5] Preliminary results of a phase II trial of dose-intense PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) in advanced pancreatic adenocarcinorna
    Reni, M.
    Cereda, S.
    Dell'Oro, S.
    Passoni, P.
    Bonetto, E.
    Vigano, M.
    Balzano, G.
    Zerbi, A.
    Staudacher, C.
    Di Carlo, V.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 225 - 226
  • [6] The Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine (PEFG) Regimen in Advanced Biliary Tract Adenocarcinoma
    Cereda, Stefano
    Passoni, Paolo
    Reni, Michele
    Vigano, Maria G.
    Aldrighetti, Luca
    Nicoletti, Roberto
    Villa, Eugenio
    [J]. CANCER, 2010, 116 (09) : 2208 - 2214
  • [7] PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) regimen in advanced biliary tract adenocarcinoma (BTA)
    Cereda, Stefano
    Reni, Michele
    Ronzoni, Monica
    Vigano, Maria Grazia
    Vitali, Giordano
    Mereu, Antonio
    Aldrighetti, Luca
    Zanello, Alessandro
    Villa, Eugenio
    Passoni, Paolo
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 319 - 320
  • [8] PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) for patients with advanced pancreatic cancer: The ghost regimen
    Reni, M.
    Cereda, S.
    Galli, L.
    [J]. CANCER LETTERS, 2007, 256 (01) : 25 - 28
  • [9] Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine in pancreatic cancer: a randomized phase II trial
    Reni, M.
    Cereda, S.
    Aprile, G.
    Tronconi, M. C.
    Milandri, C.
    Passoni, P.
    Rognone, A.
    Balzano, G.
    Di Carlo, V.
    Villa, E.
    [J]. EJC SUPPLEMENTS, 2009, 7 (02): : 390 - 390
  • [10] ADJUVANT PEFG (CISPLATIN, EPIRUBICIN, 5-FLUOROURACIL, GEMCITABINE) OR GEMCITABINE IN PANCREATIC CANCER: A RANDOMIZED PHASE II TRIAL
    Reni, Michele
    Cereda, Stefano
    Aprile, Giuseppe
    Tronconi, Maria Chiara
    Milandri, Carlo
    Saletti, Piercarlo
    Passoni, Paolo
    Rognone, Alessia
    Fugazza, Clara
    Ceraulo, Domenica
    Balzano, Gianpaolo
    Di Carlo, Valerio
    Villa, Eugenio
    [J]. ANNALS OF ONCOLOGY, 2009, 20
12345